ROYAL BANK OF CANADA - COCRYSTAL PHARMA INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of COCRYSTAL PHARMA INC
ValueSharesWeighting
Q3 2022$01000.0%0.00%
Q2 2022$0
-100.0%
100
-91.1%
0.00%
Q2 2020$2,000
-98.4%
1,120
-99.4%
0.00%
Q1 2020$126,000178,373
+140351.2%
0.00%
Q4 2019$0
-100.0%
127
-100.0%
0.00%
-100.0%
Q3 2019$1,463,000
-12.7%
713,564
+0.0%
0.00%0.0%
Q2 2019$1,676,000
-13.9%
713,2400.0%0.00%0.0%
Q1 2019$1,947,000
+27714.3%
713,240
+35419.9%
0.00%
Q4 2018$7,000
+40.0%
2,0080.0%0.00%
Q3 2018$5,000
-28.6%
2,008
+0.4%
0.00%
Q2 2018$7,000
-70.8%
2,000
-50.0%
0.00%
Q1 2018$24,0004,0000.00%
Other shareholders
COCRYSTAL PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 5,284,256$1,538,0001.94%
Parallel Advisors, LLC 182,708$53,0000.00%
Verition Fund Management LLC 320,000$47,0470.00%
Renaissance Technologies 1,604,425$467,0000.00%
Virtu Financial LLC 48,017$14,0000.00%
BANK OF AMERICA CORP /DE/ 107,695$31,0000.00%
WELLS FARGO & COMPANY/MN 1,006$00.00%
NORTHERN TRUST CORP 143,474$42,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 809,403$235,0000.00%
View complete list of COCRYSTAL PHARMA INC shareholders